Vaccine Therapy in Treating Patients With Kidney Cancer

Completed · Phase 1

Conditions studied: Kidney Cancer

In brief

RATIONALE: Vaccines made from DNA may make the body build an immune response to kill tumor cells. PURPOSE: This randomized phase I trial is studying the side effects and best dose of vaccine therapy in treating patients with kidney cancer.

Key facts

Study ID

NCT00096629

Run by

Memorial Sloan Kettering Cancer Center

People needed

15

Starts

2003-11-01

Expected to finish

2018-04-01

Last updated by the study team

2018-04-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.